15
Participants
Start Date
February 29, 2008
Primary Completion Date
June 30, 2008
Study Completion Date
August 31, 2008
LWMH in TB-402 treated subjects or TB-402 in warfarin treated subjects
Administration of LMWH in healthy male subjects treated with TB-402 and administration of TB-402 in healthy male subjects treated with warfarin
Cyncron CRU, Copenhagen
Lead Sponsor
Collaborators (1)
BioInvent International AB
INDUSTRY
ThromboGenics
INDUSTRY